Developing a prostate MRI service

Author(s): Dr Tristan Barrett

Hospital: Addenbrooke's Hospital

Reference: RAD Magazine, 45, 534, 9


The diagnosis of prostate cancer has undergone a paradigm shift in recent years, with MRI now at the forefront of the diagnostic pathway. Several high profile recent trials including the UK-led PROMIS and PRECISION studies have established the performance advantage of MRI over the traditional work-up with systematic transrectal biopsy. Leading on from this, the 2019 NICE guidelines now recommended MRI as the first-line investigation for most men referred with a suspicion of prostate cancer. However, due to a (perhaps deliberate) quirk in the wording of the 2014 edition of the NICE guidelines, a reasoned interpretation meant that the majority of UK centres have already adopted pre-biopsy MRI.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more